Combination chemotherapy with weekly docetaxel and intermittent estramustine in patients with hormone refractory prostate cancer (HRPC): A multicenter phase II study. - Miller,K.; Steiner,U.; Machtens,S. (Proc Am Soc Clin Oncol, 2003)